Epidemiology and co-infection networks of pediatric respiratory pathogens in eastern China after COVID-19 restriction relaxation: a retrospective study

新冠肺炎疫情限制措施放松后,中国东部地区儿童呼吸道病原体的流行病学及合并感染网络:一项回顾性研究

阅读:1

Abstract

OBJECTIVES: To characterize the epidemiology, seasonal fluctuations, and co-infection networks of pediatric respiratory pathogens in eastern China following the relaxation of COVID-19 non-pharmaceutical interventions (NPIs). METHODS: We conducted a retrospective analysis of 7,473 throat swab samples collected from children (≤18 years) presenting with acute respiratory tract infections (ARTIs) at a tertiary hospital in Nanjing between January 2024 and May 2025. Samples were tested for 13 common pathogens using a multiplex RT-PCR assay. Pathogen detection rates, temporal trends, and co-infection dynamics were analyzed using Kruskal-Wallis tests, time-series smoothing, and network analysis. RESULTS: The overall pathogen detection rate was 61.8% (4,618/7,473), with no significant sex disparity (p = 0.267). Preschoolers (4-6 years) experienced the highest burden (68.3%), significantly exceeding other age groups (p < 0.008). Rhinovirus (RV, 16.9%), Mycoplasma pneumoniae (12.4%), and Respiratory Syncytial Virus (RSV, 9.0%) were the most prevalent pathogens. Distinct seasonal signatures were observed: RSV peaked in winter (25.3% in March 2025), M. pneumoniae dominated in mid-summer (22.8% in August 2024), and RV maintained high year-round activity. Co-infections occurred in 17.5% of positive samples, with M. pneumoniae-RV and Adenovirus-RV being the most frequent combinations. Network analysis identified RV and M. pneumoniae as central connectors within the intricate co-infection landscape. CONCLUSIONS: Pediatric respiratory pathogens have returned with strong, age-specific patterns in post-NPI eastern China. The pronounced "immunity debt" among preschoolers and the high rate of co-infections underscore the urgent need for enhanced multiplex surveillance and the expansion of vaccination programs for RSV and influenza.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。